Crossmark

Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes

Crossref DOI link: https://doi.org/10.1186/s12933-017-0646-z

Published Online: 2018-01-08

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lambadiari, Vaia http://orcid.org/0000-0002-4620-4039
Pavlidis, George

Kousathana, Foteini

Varoudi, Maria

Vlastos, Dimitrios

Maratou, Eirini

Georgiou, Dimitrios

Andreadou, Ioanna

Parissis, John

Triantafyllidi, Helen

Lekakis, John

Iliodromitis, Efstathios

Dimitriadis, George

Ikonomidis, Ignatios
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct03010683 at ClinicalTrials.gov

Documents that mention this clinical trial

Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes
https://doi.org/10.1186/s12933-017-0646-z
License Information

Text and Data Mining valid from 2018-01-08

Version of Record valid from 2018-01-08
More Information

Article History

Received: 30 August 2017

Accepted: 23 December 2017

First Online: 8 January 2018

Document is current

Any future updates will be listed below